Emergent (EBS) news
Recent news
Emergent Biosolutions - Standing offer effective Oct 1, 2026-Sept 30, 2029 with two-year extension option
AInvest Wire · 6h agoEmergent Biosolutions - Awarded standing offer to supply Narcan nasal spray in Canada
Emergent BioSolutions has been awarded a standing offer to supply Narcan nasal spray in Canada, a development that positions the company to participate in the Canadian market for opioid overdose reversal treatments. The award reflects the ongoing demand for naloxone-based products and the company’s…
AInvest Wire · 6h agoEmergent BioSolutions Inc.: JPMorgan resumes coverage with underweight rating
AInvest Wire · Aug 21, 2026S&P: Emergent BioSolutions outlook revised to negative on lower revenue guidance, ratings affirmed
S&P Global Ratings has revised the outlook for Emergent BioSolutions Inc. to negative, citing the company’s reduced revenue guidance, while affirming its current credit ratings . The downgrade in outlook reflects concerns over the company’s near-term financial performance and the potential impact…
AInvest Wire · Aug 18, 2026Emergent BioSolutions Inc.: H.C. Wainwright cuts target price to $10 from $12
AInvest Wire · Aug 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.